Sector: Pharmaceuticals & Biotechnology

Small Cap

Hester Biosciences Share Price

Hester Biosciences Ltd.

₹1,975

-181.40(-8.41%)

Invest in HESTERBIO with up to 2.22x margin.

Trade with MTF

27th May 2026 | 3:28 PM

NSE : HESTERBIO

Open Free Demat Account

Hester Biosciences Performance

Price Movement

₹1975.00

₹1972.70

₹2179.20

↘ Today's Low↗ Today's High

1 Year Performance

₹1975.00

₹1239.30

₹2350.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,179.20

Low₹1,972.70

Open at₹2,158.00

Prev Close₹2,156.40

Volumes24.33 K

Avg Price₹2,069.44

Lower Circuit₹1,725.20

Upper Circuit₹2,587.60

Historical Performance

3M High₹2,238.70

3M Low₹1,239.30

1 Yr High₹2,350.00

1 Yr Low₹1,239.30

3 Yr High₹3,379.00

3 Yr Low₹1,239.30

5 Yr High₹3,379.00

5 Yr Low₹1,239.30

Hester Biosciences Fundamentals

Market Cap

Above industry Median

1,692.90 Cr.

PE Ratio (TTM)

Above industry Median

30.40

Dividend Yield

Below industry Median

0.40

Net Profit TTM

102.4% incr over last year

55.64

Net Profit Growth

102.4% incr over last year

55.64

PEG Ratio

Below industry Median

0.30

ROE

76.7% incr over last year

15.44

Operating Revenue TTM

332.60

Operating Revenue Growth

6.9% incr over last year

Book Value

Above industry Median

4.90

MFI

MFI strongly Overbought

87.03

RSI

RSI is mid-range

66.08

EPS (TTM)

67.57

Debt to Equity

0.52

Face Value

Operating Profit Margin Qtr.

25.32

Operating Profit Qtr.

34.33

Net Profit Qtr.

15.98

Operating Revenue Qtr.

100.11

PB Ratio

4.90

Hester Biosciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	93.71	70.35	64.58	63.49	76.67
Operating Expense	62.25	53.64	52.70	51.08	62.97
Operating Profit	31.46	16.72	11.88	12.41	13.70
Depreciation	3.68	2.21	2.20	2.16	2.03
Interest	4.09	0.90	1.27	0.90	1.25
Tax	8.49	3.97	2.67	2.45	1.85
Net Profit	26.38	10.67	7.21	7.84	9.64

Hester Biosciences Technicals

Hester Biosciences Ltd. EMA & SMA

₹1975.00

-181.40 (-8.41%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1968.6

Day EMA10 ₹1895.5

Day EMA12 ₹1871.9

Day EMA20 ₹1796.4

Day EMA26 ₹1754.2

Day EMA50 ₹1659

Day EMA100 ₹1615.8

Day EMA200 ₹1659

Hester Biosciences Support and Resistance

Resistance

First Resistance₹2121.90

Second Resistance₹2253.80

Third Resistance₹2328.40

Support

First Support₹1915.40

Second Support₹1840.80

Third Support₹1708.90

Technical Indicators

Day RSI66.08

Day MFI87.03

Day ADX57.12

Day Commodity Channel Index162.50

William-40.52

Day MACD117.69

Day MACD Signal Line93.17

Day ATR112.31

Day ROC12519.03

Day ROC2119.25

Hester Biosciences Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	53.7	53.7	53.7	53.7	53.7	53.7
FII	0.6	0.9	0.5	0.5	0.5	0.4
DII	0	0	0	0	0	0
Public	45.6	45.4	45.7	45.7	45.8	45.9

Hester Biosciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	9.98 K	26.61 K	37.50%
Week	14.32 K	42.74 K	33.51%
1 Month	7.79 K	25.75 K	30.25%
6 Month	4.09 K	8.63 K	47.37%

Hester Biosciences SWOT Analysis

Strengths29

Weakness1

Opportunity0

Threats0

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing Revenue every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Hester Biosciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
06 Aug, 2025	7	FINAL	06 Aug, 2025	Equity Share
22 Aug, 2024	6	FINAL		Equity Share
13 Sep, 2023	8	FINAL		Equity Share
11 Aug, 2022	10	FINAL		Equity Share
05 Aug, 2021	10	FINAL		Equity Share
27 Aug, 2020	6.6	FINAL		Equity Share
18 Jul, 2019	7	FINAL		Equity Share
09 Nov, 2018	2	INTERIM	12 Nov, 2018	Equity Share
30 Aug, 2018	2	INTERIM	31 Aug, 2018	Equity Share
02 Aug, 2018	6	FINAL		Equity Share

Hester Biosciences Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Innova Captab Ltd.
Price (₹)	₹486.75	₹6.46	₹132.26	₹14.29	₹563.80	₹844
% Change	0.64%	0.00%	-0.74%	1.71%	1.08%	0.06%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	-	₹502.55	₹1,630.02
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	-	₹57.92	₹140.92
PE TTM	-	-1.50	34.40	-	28.00	34.40
1 Year Return	23.66	545	4.6	56.59	-23.09	-1.99
ROCE	3.56	-5.63	-	-	23.87	15.27

Similar Stocks

VALIANTLAB

Valiant Laboratories Ltd.

₹ 80.00

+1.60%

SIGACHI

Sigachi Industries Ltd.

₹ 20.57

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 821.00

-0.22%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

+0.43%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 544.00

-2.60%

ZIMLAB

Zim Laboratories Ltd.

₹ 102.60

-0.77%

MEDICO

Medico Remedies Ltd.

₹ 49.00

+1.51%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 197.52

-1.50%

LASA

Lasa Supergenerics Ltd.

₹ 8.63

+4.99%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 372.20

-1.22%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 311.50

+2.05%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.31

+4.95%

BROOKS

Brooks Laboratories Ltd.

₹ 62.19

+5.00%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2239.00

+1.14%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 129.90

-0.20%

ALPA

Alpa Laboratories Ltd.

₹ 71.15

+0.66%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 378.90

+0.70%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.41

+1.14%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.70

-0.66%

INDOCO

Indoco Remedies Ltd.

₹ 203.00

+5.11%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 134.90

-0.93%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 760.00

+1.68%

PANACEABIO

Panacea Biotec Ltd.

₹ 413.50

-2.49%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 284.95

+4.65%

FAQ's on HESTERBIO

What is the current share price of Hester Biosciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Hester Biosciences Ltd. is ₹ 1975 on the NSE and ₹ 1980 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Hester Biosciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Hester Biosciences Ltd. is approximately ₹ 1692.9 Cr.

What are the PE and PB ratios for Hester Biosciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Hester Biosciences Ltd. is 30.4, and the Price-to-Book (PB) ratio is 4.9.

What is the 52-Week High and Low for Hester Biosciences Ltd.?

Over the past 52 weeks, the highest price reached by Hester Biosciences Ltd. shares was ₹ 2350, and the lowest price was ₹ 1239.3.

What is the current dividend yield for Hester Biosciences Ltd.?

As of 6 June 2025, the dividend yield for Hester Biosciences Ltd. is 0.4%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Hester Biosciences Ltd.?

Significant shareholdings in Hester Biosciences Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Hester Biosciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Hester Biosciences Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Hester Biosciences Ltd.?

Hester Biosciences Ltd. last declared a FINAL dividend of ₹ 7 per share for the financial period ending 2025. The record date was set as 2025-08-06, and the payment was/is scheduled around 2025-08-06. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy